Endovascular Treatment With or Without Preceding Intravenous Tenecteplase (TNK) in Patients With Late-window acUte Ischemic Stroke Due to Middle Cerebral Artery Occlusion (TNK-PLUS)
Endovascular Treatment With or Without Preceding Intravenous Tenecteplase (TNK) in Patients With Late-window acUte Ischemic Stroke Due to Middle Cerebral Artery Occlusion: a Multi-center, Prospective, Randomized, Open-label, Blinded Endpoint (PROBE), Phase 3 Trial
Sponsor: Beijing Tiantan Hospital
A PHASE3 clinical study on Endovascular Treatment and Ischemic Stroke, Acute, this trial is completed. The trial is conducted by Beijing Tiantan Hospital and has accumulated 5 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
Dec 2025 — Present [monthly]
Completed PHASE3
Status: Recruiting → Completed
-
Sep 2024 — Dec 2025 [monthly]
Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE3
-
Jun 2024 — Jul 2024 [monthly]
Recruiting PHASE3
Status: Active Not Recruiting → Recruiting
-
Feb 2024 — Jun 2024 [monthly]
Active Not Recruiting PHASE3
First recorded
Jan 2024
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Beijing Tiantan Hospital
- Linyi People's Hospital
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Beijing, China , Chenzhou, China , Dalian, China , Hangzhou, China , Harbin, China , Hefei, China , Heze, China , Jining, China , Liaocheng, China , Linyi, China and 8 more locations